nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0552	0.0797	CbGbCtD
Glipizide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0519	0.0749	CbGbCtD
Glipizide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0519	0.0749	CbGbCtD
Glipizide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0469	0.0678	CbGbCtD
Glipizide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0469	0.0678	CbGbCtD
Glipizide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0405	0.0585	CbGbCtD
Glipizide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0393	0.0568	CbGbCtD
Glipizide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0356	0.0514	CbGbCtD
Glipizide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0356	0.0514	CbGbCtD
Glipizide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0341	0.0492	CbGbCtD
Glipizide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0321	0.0463	CbGbCtD
Glipizide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0302	0.0436	CbGbCtD
Glipizide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0302	0.0436	CbGbCtD
Glipizide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0273	0.0394	CbGbCtD
Glipizide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0273	0.0394	CbGbCtD
Glipizide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0236	0.034	CbGbCtD
Glipizide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0229	0.033	CbGbCtD
Glipizide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0207	0.0299	CbGbCtD
Glipizide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0207	0.0299	CbGbCtD
Glipizide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0198	0.0286	CbGbCtD
Glipizide—PPARG—endothelium—acquired immunodeficiency syndrome	0.00328	0.0987	CbGeAlD
Glipizide—PPARG—blood plasma—acquired immunodeficiency syndrome	0.00291	0.0877	CbGeAlD
Glipizide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.0017	0.0514	CbGeAlD
Glipizide—KCNJ11—lymphoid tissue—acquired immunodeficiency syndrome	0.00161	0.0486	CbGeAlD
Glipizide—PPARG—skin of body—acquired immunodeficiency syndrome	0.0014	0.0422	CbGeAlD
Glipizide—ABCC8—spinal cord—acquired immunodeficiency syndrome	0.00135	0.0405	CbGeAlD
Glipizide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.0013	0.0392	CbGeAlD
Glipizide—KCNJ11—nervous system—acquired immunodeficiency syndrome	0.00123	0.0371	CbGeAlD
Glipizide—KCNJ11—central nervous system—acquired immunodeficiency syndrome	0.00119	0.0357	CbGeAlD
Glipizide—ABCC8—nervous system—acquired immunodeficiency syndrome	0.00113	0.0342	CbGeAlD
Glipizide—PPARG—lymphoid tissue—acquired immunodeficiency syndrome	0.00113	0.0341	CbGeAlD
Glipizide—PPARG—digestive system—acquired immunodeficiency syndrome	0.00112	0.0337	CbGeAlD
Glipizide—ABCC8—central nervous system—acquired immunodeficiency syndrome	0.00109	0.0329	CbGeAlD
Glipizide—PPARG—blood—acquired immunodeficiency syndrome	0.00107	0.0321	CbGeAlD
Glipizide—PPARG—bone marrow—acquired immunodeficiency syndrome	0.00103	0.0311	CbGeAlD
Glipizide—PPARG—vagina—acquired immunodeficiency syndrome	0.000988	0.0298	CbGeAlD
Glipizide—KCNJ11—brain—acquired immunodeficiency syndrome	0.000941	0.0284	CbGeAlD
Glipizide—PPARG—lung—acquired immunodeficiency syndrome	0.000935	0.0282	CbGeAlD
Glipizide—KCNJ11—lymph node—acquired immunodeficiency syndrome	0.000909	0.0274	CbGeAlD
Glipizide—ABCC8—brain—acquired immunodeficiency syndrome	0.000867	0.0261	CbGeAlD
Glipizide—PPARG—nervous system—acquired immunodeficiency syndrome	0.000866	0.0261	CbGeAlD
Glipizide—PPARG—central nervous system—acquired immunodeficiency syndrome	0.000833	0.0251	CbGeAlD
Glipizide—PPARG—brain—acquired immunodeficiency syndrome	0.000662	0.0199	CbGeAlD
Glipizide—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000655	0.0197	CbGeAlD
Glipizide—PPARG—lymph node—acquired immunodeficiency syndrome	0.000639	0.0193	CbGeAlD
Glipizide—CYP2C9—blood—acquired immunodeficiency syndrome	0.000624	0.0188	CbGeAlD
Glipizide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.0005	0.0151	CbGeAlD
Glipizide—CYP3A4—blood—acquired immunodeficiency syndrome	0.000476	0.0143	CbGeAlD
Glipizide—Gliclazide—ALB—acquired immunodeficiency syndrome	0.000462	0.655	CrCbGaD
Glipizide—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000387	0.0116	CbGeAlD
Glipizide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000372	0.0112	CbGeAlD
Glipizide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000275	0.00101	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000275	0.00101	CcSEcCtD
Glipizide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000274	0.001	CcSEcCtD
Glipizide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000274	0.001	CcSEcCtD
Glipizide—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000273	0.000999	CcSEcCtD
Glipizide—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000273	0.000999	CcSEcCtD
Glipizide—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000273	0.000999	CcSEcCtD
Glipizide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.000995	CcSEcCtD
Glipizide—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000272	0.000995	CcSEcCtD
Glipizide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000271	0.000993	CcSEcCtD
Glipizide—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000271	0.000992	CcSEcCtD
Glipizide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000271	0.000992	CcSEcCtD
Glipizide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000271	0.000992	CcSEcCtD
Glipizide—Headache—Didanosine—acquired immunodeficiency syndrome	0.00027	0.000986	CcSEcCtD
Glipizide—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000269	0.000985	CcSEcCtD
Glipizide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000269	0.000984	CcSEcCtD
Glipizide—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000269	0.000983	CcSEcCtD
Glipizide—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.000982	CcSEcCtD
Glipizide—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000269	0.000982	CcSEcCtD
Glipizide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000268	0.000981	CcSEcCtD
Glipizide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000268	0.000979	CcSEcCtD
Glipizide—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000268	0.000979	CcSEcCtD
Glipizide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000267	0.000978	CcSEcCtD
Glipizide—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.000977	CcSEcCtD
Glipizide—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.000977	CcSEcCtD
Glipizide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.000975	CcSEcCtD
Glipizide—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.000974	CcSEcCtD
Glipizide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000266	0.000973	CcSEcCtD
Glipizide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000266	0.000972	CcSEcCtD
Glipizide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000265	0.00097	CcSEcCtD
Glipizide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000265	0.000969	CcSEcCtD
Glipizide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000264	0.000967	CcSEcCtD
Glipizide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000264	0.000966	CcSEcCtD
Glipizide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000264	0.000966	CcSEcCtD
Glipizide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.000964	CcSEcCtD
Glipizide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000263	0.000964	CcSEcCtD
Glipizide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000263	0.000964	CcSEcCtD
Glipizide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000263	0.000961	CcSEcCtD
Glipizide—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000263	0.00096	CcSEcCtD
Glipizide—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.000957	CcSEcCtD
Glipizide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000261	0.000954	CcSEcCtD
Glipizide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00026	0.000953	CcSEcCtD
Glipizide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.000952	CcSEcCtD
Glipizide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.000952	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.000951	CcSEcCtD
Glipizide—Pain—Indinavir—acquired immunodeficiency syndrome	0.000258	0.000945	CcSEcCtD
Glipizide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000258	0.000945	CcSEcCtD
Glipizide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.000944	CcSEcCtD
Glipizide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000258	0.000944	CcSEcCtD
Glipizide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.000941	CcSEcCtD
Glipizide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000257	0.000939	CcSEcCtD
Glipizide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000256	0.000938	CcSEcCtD
Glipizide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000256	0.000937	CcSEcCtD
Glipizide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.000937	CcSEcCtD
Glipizide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000256	0.000935	CcSEcCtD
Glipizide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000256	0.000935	CcSEcCtD
Glipizide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.000934	CcSEcCtD
Glipizide—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.000932	CcSEcCtD
Glipizide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.000931	CcSEcCtD
Glipizide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000254	0.000931	CcSEcCtD
Glipizide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000254	0.00093	CcSEcCtD
Glipizide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000254	0.000928	CcSEcCtD
Glipizide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.000927	CcSEcCtD
Glipizide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.000927	CcSEcCtD
Glipizide—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000253	0.000924	CcSEcCtD
Glipizide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.000924	CcSEcCtD
Glipizide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000252	0.000921	CcSEcCtD
Glipizide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000251	0.000919	CcSEcCtD
Glipizide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00025	0.000916	CcSEcCtD
Glipizide—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00025	0.000913	CcSEcCtD
Glipizide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000249	0.000911	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.00091	CcSEcCtD
Glipizide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000248	0.000909	CcSEcCtD
Glipizide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000248	0.000908	CcSEcCtD
Glipizide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000248	0.000907	CcSEcCtD
Glipizide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.000904	CcSEcCtD
Glipizide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000247	0.000904	CcSEcCtD
Glipizide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000247	0.000904	CcSEcCtD
Glipizide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.000903	CcSEcCtD
Glipizide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000246	0.000901	CcSEcCtD
Glipizide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000246	0.0009	CcSEcCtD
Glipizide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000245	0.000897	CcSEcCtD
Glipizide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.000896	CcSEcCtD
Glipizide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000244	0.000893	CcSEcCtD
Glipizide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000244	0.000893	CcSEcCtD
Glipizide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000244	0.000893	CcSEcCtD
Glipizide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000244	0.000893	CcSEcCtD
Glipizide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000244	0.000892	CcSEcCtD
Glipizide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.000891	CcSEcCtD
Glipizide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000243	0.000891	CcSEcCtD
Glipizide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.000889	CcSEcCtD
Glipizide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.000888	CcSEcCtD
Glipizide—Glyburide—ALB—acquired immunodeficiency syndrome	0.000243	0.344	CrCbGaD
Glipizide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000242	0.000887	CcSEcCtD
Glipizide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.000885	CcSEcCtD
Glipizide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.000885	CcSEcCtD
Glipizide—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000241	0.000882	CcSEcCtD
Glipizide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.000881	CcSEcCtD
Glipizide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00024	0.000879	CcSEcCtD
Glipizide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00024	0.000878	CcSEcCtD
Glipizide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000239	0.000875	CcSEcCtD
Glipizide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.000874	CcSEcCtD
Glipizide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000239	0.000873	CcSEcCtD
Glipizide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000238	0.000872	CcSEcCtD
Glipizide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00087	CcSEcCtD
Glipizide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000238	0.000869	CcSEcCtD
Glipizide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000237	0.000868	CcSEcCtD
Glipizide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000236	0.000865	CcSEcCtD
Glipizide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000236	0.000864	CcSEcCtD
Glipizide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000236	0.000862	CcSEcCtD
Glipizide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000236	0.000862	CcSEcCtD
Glipizide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000235	0.000861	CcSEcCtD
Glipizide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.00086	CcSEcCtD
Glipizide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000235	0.000859	CcSEcCtD
Glipizide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000235	0.000859	CcSEcCtD
Glipizide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000234	0.000856	CcSEcCtD
Glipizide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000234	0.000856	CcSEcCtD
Glipizide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.000855	CcSEcCtD
Glipizide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.000854	CcSEcCtD
Glipizide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.000854	CcSEcCtD
Glipizide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000233	0.000854	CcSEcCtD
Glipizide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000233	0.000852	CcSEcCtD
Glipizide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000232	0.000849	CcSEcCtD
Glipizide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000232	0.000848	CcSEcCtD
Glipizide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000848	CcSEcCtD
Glipizide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.000847	CcSEcCtD
Glipizide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000231	0.000844	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000842	CcSEcCtD
Glipizide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00023	0.000841	CcSEcCtD
Glipizide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.000841	CcSEcCtD
Glipizide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000835	CcSEcCtD
Glipizide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000228	0.000834	CcSEcCtD
Glipizide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00083	CcSEcCtD
Glipizide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.000829	CcSEcCtD
Glipizide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.000829	CcSEcCtD
Glipizide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000226	0.000825	CcSEcCtD
Glipizide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.000824	CcSEcCtD
Glipizide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.000823	CcSEcCtD
Glipizide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.000821	CcSEcCtD
Glipizide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000224	0.00082	CcSEcCtD
Glipizide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.000817	CcSEcCtD
Glipizide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000223	0.000814	CcSEcCtD
Glipizide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000223	0.000814	CcSEcCtD
Glipizide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.000813	CcSEcCtD
Glipizide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000222	0.000813	CcSEcCtD
Glipizide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000222	0.000812	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00081	CcSEcCtD
Glipizide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.000808	CcSEcCtD
Glipizide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.000804	CcSEcCtD
Glipizide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.000803	CcSEcCtD
Glipizide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000219	0.0008	CcSEcCtD
Glipizide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.000798	CcSEcCtD
Glipizide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.000797	CcSEcCtD
Glipizide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.000794	CcSEcCtD
Glipizide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000217	0.000793	CcSEcCtD
Glipizide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.000793	CcSEcCtD
Glipizide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.00079	CcSEcCtD
Glipizide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.00079	CcSEcCtD
Glipizide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.00079	CcSEcCtD
Glipizide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000216	0.00079	CcSEcCtD
Glipizide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000215	0.000786	CcSEcCtD
Glipizide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.000783	CcSEcCtD
Glipizide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000214	0.000782	CcSEcCtD
Glipizide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.000773	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000773	CcSEcCtD
Glipizide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.000769	CcSEcCtD
Glipizide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000768	CcSEcCtD
Glipizide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.000767	CcSEcCtD
Glipizide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000762	CcSEcCtD
Glipizide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000761	CcSEcCtD
Glipizide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.00076	CcSEcCtD
Glipizide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.00076	CcSEcCtD
Glipizide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000756	CcSEcCtD
Glipizide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000207	0.000756	CcSEcCtD
Glipizide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000207	0.000755	CcSEcCtD
Glipizide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.000755	CcSEcCtD
Glipizide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000754	CcSEcCtD
Glipizide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.000749	CcSEcCtD
Glipizide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.000749	CcSEcCtD
Glipizide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.000748	CcSEcCtD
Glipizide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000747	CcSEcCtD
Glipizide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000203	0.000744	CcSEcCtD
Glipizide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.000739	CcSEcCtD
Glipizide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.000737	CcSEcCtD
Glipizide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.000736	CcSEcCtD
Glipizide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000734	CcSEcCtD
Glipizide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000733	CcSEcCtD
Glipizide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000732	CcSEcCtD
Glipizide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.0002	0.000731	CcSEcCtD
Glipizide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.00073	CcSEcCtD
Glipizide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000727	CcSEcCtD
Glipizide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.000725	CcSEcCtD
Glipizide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.000725	CcSEcCtD
Glipizide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.000717	CcSEcCtD
Glipizide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.000714	CcSEcCtD
Glipizide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.000707	CcSEcCtD
Glipizide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000706	CcSEcCtD
Glipizide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000193	0.000706	CcSEcCtD
Glipizide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000703	CcSEcCtD
Glipizide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000192	0.000703	CcSEcCtD
Glipizide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000699	CcSEcCtD
Glipizide—Rash—Indinavir—acquired immunodeficiency syndrome	0.00019	0.000697	CcSEcCtD
Glipizide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00019	0.000696	CcSEcCtD
Glipizide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000694	CcSEcCtD
Glipizide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000189	0.000692	CcSEcCtD
Glipizide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.00069	CcSEcCtD
Glipizide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.000683	CcSEcCtD
Glipizide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000681	CcSEcCtD
Glipizide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000674	CcSEcCtD
Glipizide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.00067	CcSEcCtD
Glipizide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000181	0.000664	CcSEcCtD
Glipizide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000663	CcSEcCtD
Glipizide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.000661	CcSEcCtD
Glipizide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.000658	CcSEcCtD
Glipizide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.000658	CcSEcCtD
Glipizide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000179	0.000656	CcSEcCtD
Glipizide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000655	CcSEcCtD
Glipizide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.000654	CcSEcCtD
Glipizide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000654	CcSEcCtD
Glipizide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000638	CcSEcCtD
Glipizide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.000635	CcSEcCtD
Glipizide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000632	CcSEcCtD
Glipizide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.00063	CcSEcCtD
Glipizide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.000629	CcSEcCtD
Glipizide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000629	CcSEcCtD
Glipizide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.000626	CcSEcCtD
Glipizide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000625	CcSEcCtD
Glipizide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.00062	CcSEcCtD
Glipizide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000611	CcSEcCtD
Glipizide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000609	CcSEcCtD
Glipizide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000608	CcSEcCtD
Glipizide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.0006	CcSEcCtD
Glipizide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.000593	CcSEcCtD
Glipizide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000588	CcSEcCtD
Glipizide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000587	CcSEcCtD
Glipizide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000582	CcSEcCtD
Glipizide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000582	CcSEcCtD
Glipizide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.00058	CcSEcCtD
Glipizide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000579	CcSEcCtD
Glipizide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000565	CcSEcCtD
Glipizide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000561	CcSEcCtD
Glipizide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000561	CcSEcCtD
Glipizide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.00056	CcSEcCtD
Glipizide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000557	CcSEcCtD
Glipizide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000549	CcSEcCtD
Glipizide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000539	CcSEcCtD
Glipizide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000535	CcSEcCtD
Glipizide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000534	CcSEcCtD
Glipizide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000531	CcSEcCtD
Glipizide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000528	CcSEcCtD
Glipizide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000504	CcSEcCtD
